Cover Image
Market Research Report

Animal Pharm New World of Innovation in Animal Care

Published by Animal Pharm Product code 854750
Published Content info 42 Pages
Delivery time: 1-2 business days
Price
Back to Top
Animal Pharm New World of Innovation in Animal Care
Published: December 1, 2018 Content info: 42 Pages
Description

This report explores how the top animal care companies are beginning to converge technologies in animal nutrition, diagnostics, vaccines and therapeutics. Over the past 30 years the amount of research investment has disappeared across the industry creating a requirement for innovative new products and services.

The report - produced in partnership with Stonehaven Consulting - profiles the top 12 players and includes a 10 year outlook to describe how we see the market evolving.

Table of Contents
Product Code: 90431

Table of Contents

Contents

About the author

Disclaimer

Executive Summary

Chapter 1: The New World of Innovation in Animal Care

  • 1.1. Evolution in the animal health industry
  • 1.2. Less investment in antimicrobial research
  • 1.3. The humanization of pets and effects on pet owner spending
  • 1.4. Digitalization and the “Internet of Things”
  • 1.5. Today's core challenge - traditional sources of innovation have evolved or disappeared
  • 1.6. Top companies continue to make significant investments in research
  • 1.7. Developing differentiation in R&D programs
  • 1.8. New sources of innovation

Chapter 2: The Top 12

  • 2.1. Traditional Animal Health Companies
  • 2.2. Zoetis
  • 2.3. Boehringer Ingelheim Animal Health
  • 2.4. Merck Animal Health (MSD ex-US)
  • 2.5. Animal Nutrition Companies - Livestock and Pet Sectors
  • 2.6. Livestock Nutrition
    • 2.6.1. Cargill
    • 2.6.2. Arm & Hammer Animal Nutrition
    • 2.6.3. DSM Animal Nutrition and Health
  • 2.7. Pet Nutrition
    • 2.7.1. Mars Petcare
    • 2.7.2. Nestlé Purina PetCare
    • 2.7.3. Hill's Pet Nutrition
  • 2.8. Diagnostics Companies
  • 2.9. IDEXX Laboratories
  • 2.10. Abaxis
  • 2.11. Heska

Chapter 3: Conclusions and Outlook

  • 3.1. What lies ahead
  • 3.2. Crossover examples
  • 3.3. An intersection between nutrition and health
  • 3.4. Microbiome research could become a factor
  • 3.5. Key future investment segments
  • 3.6. Future geographic expansion
  • 3.7. Outlook for the future

List of Figures

  • Figure 1: Projected 5-year market growth ($ billion)
  • Figure 2: Access to human pharma R&D diminished
  • Figure 3: Estimated R&D spend among animal health's leaders in fiscal 2017 ($ million)
Back to Top